The HLTH Community & Novartis report, Unblocking Innovations in Drug Development, presents an in-depth analysis of five key blockers—ranging from technical feasibility and regulatory acceptance to internal alignment and operational complexity—that often cause digital solutions to fail.
Through longitudinal tracking of over 150 digital solutions at Novartis and insights from 21 industry experts, the report highlights high-risk AI-driven innovations like predictive algorithms, wearables, and decentralized trials, while also offering practical, actionable strategies to overcome these barriers. Readers will gain valuable insights into real-world failures and successes, helping the industry accelerate digital transformation and bring medicines to patients faster.
Take a look at the report here.
Discover more about HLTH Community:
The HLTH Community is a platform where healthcare’s brightest minds converge to shape the future of health. We provide a year-round platform that transcends traditional networking, offering unparalleled collaboration, insight-sharing, and innovation opportunities. From our always-on digital platform to flagship events, exclusive think tanks, and masterclasses, we empower healthcare leaders to drive continuous growth and create lasting impact in an ever-evolving landscape.
